DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
Sponsor: M.D. Anderson Cancer Center
Listed as NCT02633111, this observational or N/A phase trial focuses on Aggressive and B-cell Non-Hodgkin Lymphoma and remains ongoing. Sponsored by M.D. Anderson Cancer Center, it has been updated 22 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
22 versions recorded-
Dec 2025 — Present [monthly]
Active Not Recruiting
-
Dec 2024 — Dec 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting
▶ Show 17 earlier versions
-
Apr 2023 — Dec 2023 [monthly]
Active Not Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Active Not Recruiting
-
Dec 2021 — Sep 2022 [monthly]
Active Not Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Apr 2020 — Aug 2020 [monthly]
Recruiting
-
Dec 2019 — Apr 2020 [monthly]
Recruiting
Phase: NA → None
-
Nov 2019 — Dec 2019 [monthly]
Recruiting NA
-
Aug 2019 — Nov 2019 [monthly]
Recruiting NA
-
May 2019 — Aug 2019 [monthly]
Recruiting NA
-
Nov 2018 — May 2019 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
Aug 2017 — Jun 2018 [monthly]
Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- M.D. Anderson Cancer Center
- Mayo Clinic
- Memorial Sloan Kettering Cancer Center
- University of Miami
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .